PHQ-9 vs GAD-7: Depression vs Anxiety Screening Explained

Quick Answer: PHQ-9 screens for depression (9 questions about sadness, loss of interest, sleep changes). GAD-7 screens for anxiety (7 questions about worry, nervousness, restlessness). Both use similar scoring (≥10 indicates positive screen), but they measure different conditions. Many professionals recommend using both together because depression and anxiety frequently occur together, and a depression questionnaire does not ask about anxiety.

---

Side-by-Side Comparison

---

PHQ-9: Patient Health Questionnaire-9 (Depression Screening)

What It Measures

The PHQ-9 is a 9-item questionnaire that screens for major depressive disorder. Each question scores one of the nine DSM-IV symptom criteria for depression, the same nine symptoms DSM-5 uses.

The 9 symptoms assessed:

1. Little interest or pleasure in doing things
2. Feeling down, depressed, or hopeless
3. Trouble falling/staying asleep, or sleeping too much
4. Feeling tired or having little energy
5. Poor appetite or overeating
6. Feeling bad about yourself (failure, letting others down)
7. Trouble concentrating on things
8. Moving/speaking slowly or being fidgety/restless
9. Thoughts of being better off dead or hurting yourself

How Scoring Works

Each item is scored 0-3:

• 0 = Not at all
• 1 = Several days
• 2 = More than half the days
• 3 = Nearly every day

Total score (0-27) interpretation:

• 0-4: Minimal or no depression
• 5-9: Mild depression
• 10-14: Moderate depression (positive screen)
• 15-19: Moderately severe depression
• 20-27: Severe depression

Positive screen threshold: ≥10 (moderate or greater depression)

Special Feature: Question 9 (Suicidal Ideation)

PHQ-9 includes a critical safety question about thoughts of self-harm or death. Any answer other than "not at all" on Question 9 needs a suicide-risk assessment by a qualified clinician, whatever the total score. The questionnaire cannot judge the risk itself; the official instructions say that "requires a clinical interview." If you are in crisis now, call or text 988 in the United States.

Strengths of PHQ-9

• Based on the DSM symptom criteria - one question per diagnostic symptom
• High sensitivity and specificity (88% for both in primary care)
• Dual purpose - screening and severity measurement
• Can support diagnosis - provides information for clinical assessment
• Widely validated - thousands of studies across populations
• Monitors treatment response - repeat scores track improvement
• Quick administration - 2-3 minutes

Limitations of PHQ-9

• Not a diagnosis - requires clinical evaluation for confirmation
• Can miss anxiety - focused on depressive symptoms only
• Cultural sensitivity - some items may not translate well across cultures
• Somatic symptoms - physical illness can inflate scores (fatigue, sleep, appetite)
• Bipolar screening - doesn't screen for manic/hypomanic episodes

---

GAD-7: Generalized Anxiety Disorder-7 (Anxiety Screening)

What It Measures

The GAD-7 is a 7-item questionnaire that screens for generalized anxiety disorder. It's the most widely used brief measure for anxiety symptoms.

The 7 symptoms assessed:

1. Feeling nervous, anxious, or on edge
2. Not being able to stop or control worrying
3. Worrying too much about different things
4. Trouble relaxing
5. Being so restless that it's hard to sit still
6. Becoming easily annoyed or irritable
7. Feeling afraid as if something awful might happen

How Scoring Works

Each item is scored 0-3:

• 0 = Not at all
• 1 = Several days
• 2 = More than half the days
• 3 = Nearly every day

Total score (0-21) interpretation:

• 0-4: Minimal anxiety
• 5-9: Mild anxiety
• 10-14: Moderate anxiety (positive screen)
• 15-21: Severe anxiety

Positive screen threshold: ≥10 (moderate or greater anxiety)

Strengths of GAD-7

• Widely used for anxiety screening - one of the most studied brief anxiety measures
• High sensitivity (89%) and specificity (82%) in primary care
• Broad anxiety detection - screens for GAD, panic disorder, social anxiety, PTSD
• Quick and simple - 7 questions, 1-2 minutes
• Can be used for monitoring - tracks anxiety symptoms over time, though the evidence for this is less established than for the PHQ-9
• Well-validated - extensive research across settings and populations
• Free and accessible - public domain tool

Limitations of GAD-7

• Screening only - not diagnostic, requires clinical follow-up
• Less specific - can detect multiple anxiety disorders (not just GAD)
• Doesn't assess panic attacks - may miss specific panic disorder features
• No suicidal ideation question - unlike PHQ-9, doesn't directly assess self-harm risk
• Physical symptoms - can overlap with medical conditions (restlessness, trouble relaxing)

---

When to Use PHQ-9

Use PHQ-9 when screening for depression or monitoring treatment:

Primary Care Screening

• Annual wellness visits
• Patients reporting low mood or loss of interest
• Chronic disease management (diabetes, heart disease, cancer)
• Postpartum depression screening

Symptoms Suggesting Depression

• Persistent sadness or empty mood
• Loss of interest in activities once enjoyed
• Sleep changes (insomnia or hypersomnia)
• Appetite/weight changes
• Fatigue and low energy
• Feelings of worthlessness or guilt
• Difficulty concentrating or making decisions
• Thoughts of death or suicide

Treatment Monitoring

• Repeat the PHQ-9 at follow-up visits during depression treatment, at intervals the clinician sets
• Track score changes (response is usually defined as a 50% drop together with a score below 10)
• Adjust therapy based on score trends

---

When to Use GAD-7

Use GAD-7 when screening for anxiety disorders or monitoring treatment:

Primary Care Screening

• Annual wellness visits
• Patients reporting excessive worry or nervousness
• Cardiac symptoms without clear cause (anxiety-driven palpitations)
• Insomnia or sleep disturbances

Symptoms Suggesting Anxiety

• Excessive worry that's difficult to control
• Feeling on edge or restless
• Trouble relaxing
• Irritability
• Muscle tension
• Difficulty concentrating due to worry
• Sleep disturbance due to racing thoughts

Treatment Monitoring

• Repeat the GAD-7 at follow-up visits during anxiety treatment, at intervals the clinician sets
• Track score changes to assess therapy effectiveness
• Adjust medication or psychotherapy based on trends

---

Why Use Both Together?

High Comorbidity

Depression and anxiety frequently occur together:

• In a large Dutch cohort, 67% of people with a depressive disorder also had a current anxiety disorder (Lamers 2011)
• In the same study, 63% of people with a current anxiety disorder also had a depressive disorder
• The PHQ-9 has no anxiety questions, so someone with anxiety alone can score low on it. How much a second questionnaire adds is debated: in one primary care study, PHQ-9 and GAD-7 scores fell in the same severity class 56% of the time and the added value of using both was judged "moderate" (Newman 2022)

Better Clinical Picture

Using both tools provides:

• Comprehensive assessment - captures both mood and anxiety symptoms
• Differential clarity - helps distinguish primary vs secondary symptoms
• Treatment planning - informs whether to target depression, anxiety, or both
• Monitoring flexibility - track both symptom domains over time

When to Administer Both

Always use both in these situations:

1. Initial mental health screening - comprehensive baseline
2. Unclear presentation - symptoms overlap between depression and anxiety
3. Treatment-resistant cases - may have unrecognized comorbidity
4. Chronic medical illness - depression and anxiety both common
5. Substance use patients - high rates of both conditions

---

The Combined PHQ-ADS Score

Some clinicians use the PHQ-ADS (Anxiety and Depression Scale), which combines PHQ-9 and GAD-7:

• Total score range: 0-48 (27 from PHQ-9 + 21 from GAD-7)
• Provides single measure of overall mental health symptom burden
• Useful for tracking general psychological distress
• Initial validation used baseline data from three clinical trials (Kroenke 2016); the authors call for validation in other populations

---

Scoring Interpretation: What to Do After Screening

PHQ-9 Score Action Steps

These are proposals for clinicians, not instructions for patients. A score is not a diagnosis; treatment decisions belong to a clinician who has spoken with the person.

Any positive response to Question 9 (self-harm): Needs a suicide-risk assessment by a qualified clinician. In a crisis, call or text 988 (United States).

GAD-7 Score Action Steps

Unlike the PHQ-9, the GAD-7 has no published table of treatment actions. The US Preventive Services Task Force says a positive anxiety screen needs "a confirmatory diagnostic assessment."

---

Clinical Scenarios: Which Tool to Use

Scenario 1: Annual Physical Exam (Healthy Adult, No Symptoms)

Recommendation: Screen with both PHQ-9 and GAD-7 for comprehensive mental health screening

• Takes 3-5 minutes total
• Establishes baseline scores
• Detects early or subclinical symptoms
• In line with the US Preventive Services Task Force (June 2023), which recommends depression screening for all adults and anxiety screening for adults 64 or younger; for adults 65 and over it found the evidence on anxiety screening insufficient

Scenario 2: Patient Reports "Feeling Down" and "Can't Sleep"

Start with: PHQ-9

• Depressive symptoms are primary complaint
• PHQ-9 includes sleep items
• If score is positive, consider adding GAD-7 (insomnia is common in both depression and anxiety)

Scenario 3: Patient Reports "Constant Worry" and "Racing Heart"

Start with: GAD-7

• Anxiety symptoms are primary complaint
• GAD-7 captures worry and tension
• Consider cardiac workup if palpitations are prominent
• Add PHQ-9 if anxiety screen is positive (check for comorbid depression)

Scenario 4: Patient on Antidepressant for 4 Weeks, Follow-Up Visit

Use: PHQ-9 (and GAD-7 if initially elevated)

• Monitor treatment response with same tool used at baseline
• A 50% reduction in PHQ-9 score together with a score below 10 = response
• If score isn't improving, reassess diagnosis and treatment plan

Scenario 5: Patient with Chronic Pain, Fatigue, Poor Concentration

Use: Both PHQ-9 and GAD-7

• Symptoms overlap with both depression and medical illness
• Chronic pain is strongly associated with depression
• Anxiety also common in chronic illness
• Distinguish psychological from purely physical symptoms

Scenario 6: College Student, Stressed About Exams, Can't Relax

Start with: GAD-7

• Situational stress with anxiety symptoms
• Worrying and difficulty relaxing are primary
• If GAD-7 is elevated, add PHQ-9 to check for depressive symptoms
• May be adjustment reaction rather than disorder (scores often normalize after stressor resolves)

---

Key Differences Summary

Primary Symptom Focus

PHQ-9:

• Anhedonia (loss of pleasure)
• Depressed mood
• Sleep disturbances
• Appetite changes
• Guilt and worthlessness
• Suicidal ideation

GAD-7:

• Excessive worry
• Nervousness and tension
• Restlessness
• Irritability
• Fear and apprehension
• Difficulty relaxing

Diagnostic Alignment

PHQ-9:

• One question for each of the nine DSM symptom criteria for Major Depressive Disorder
• Can help support MDD diagnosis (requires 5+ symptoms including depressed mood or anhedonia)

GAD-7:

• Assesses generalized anxiety symptoms
• Screens broadly for multiple anxiety disorders (GAD, panic, social anxiety, PTSD)
• Less specific to single DSM-5 diagnosis

Clinical Utility

PHQ-9:

• Better for diagnosis support (DSM-aligned)
• Includes safety screening (suicidal ideation)
• More widely used in primary care

GAD-7:

• Better for broad anxiety detection
• Simpler and faster (7 vs 9 items)
• Can be used as a treatment monitoring tool (evidence is less established than for the PHQ-9)

---

Common Questions

Can I use just one instead of both?

You can, but you risk missing important symptoms. If you only have time for one, use:

• PHQ-9 if depressive symptoms (sadness, loss of interest) are primary
• GAD-7 if anxiety symptoms (worry, nervousness) are primary
• Both for comprehensive screening (recommended)

The PHQ-9 has no anxiety questions, so it can miss someone whose main problem is anxiety. Research on how much the second questionnaire adds is mixed: one primary care study called the added value "moderate" (Newman 2022).

What if both scores are elevated?

This is common: depression and anxiety disorders often occur together. Next steps:

1. Confirm symptoms through clinical interview
2. Determine which is primary vs secondary
3. Consider combined treatment (therapy + medication targeting both)
4. Refer to mental health specialist if severe
5. Monitor both scores to track treatment response

How often should I repeat these screenings?

Initial screening:

• There is no evidence-based interval. The US Preventive Services Task Force "found no evidence on the optimal frequency of screening" for either depression or anxiety.
• It suggests a pragmatic approach: screen adults who have not been screened before, and use clinical judgment for people at higher risk.

During treatment:

• The official instruction manual gives no fixed schedule. Clinicians repeat the questionnaire at follow-up visits, at intervals they set for the person.

What if someone scores positive on just one question?

PHQ-9 Question 9 (suicidal ideation): Any answer other than "not at all" needs a suicide-risk assessment by a qualified clinician, whatever the total score

Other items: Consider clinical context. One elevated item may reflect situational stress rather than disorder. If you are concerned, talk to a clinician.

Are these tools valid for adolescents?

Partly. The evidence is stronger for the PHQ-9 than for the GAD-7, and cut-offs differ from adults:

• PHQ-9: in a study of 442 young people aged 13-17, a score of 11 or more best detected major depression (sensitivity 89.5%, specificity 77.5%; Richardson 2010)
• GAD-7: evidence in adolescents is limited and cut-offs vary by study; one small study of adolescents with generalized anxiety disorder found 11 or more for moderate and 17 or more for severe anxiety (Mossman 2017)

The PHQ-A is a version of the questionnaire made for adolescents. Younger children need an assessment from a pediatric clinician rather than an adult questionnaire.

Can these diagnose depression or anxiety?

No. PHQ-9 and GAD-7 are screening tools, not diagnostic tools. They identify people who may have depression or anxiety and need further evaluation. A diagnosis requires:

• Clinical interview by qualified professional
• Assessment of symptom duration, severity, and impairment
• Exclusion of other medical/psychiatric causes
• Consideration of full DSM-5 criteria

Do I need a mental health professional to administer these?

No. Both tools can be:

• Self-administered by patients
• Administered by nurses, medical assistants, or primary care staff
• Scored immediately (simple addition)
• Used in primary care, specialty care, or community settings

However, interpretation and clinical follow-up should involve a qualified healthcare provider.

What's a clinically meaningful change in score?

Treatment response benchmarks:

• 50% reduction together with a score below 10 = treatment response (the definition from the original PHQ-9 study)
• Score drops below 5 = remission
• These benchmarks were defined for the PHQ-9. No equivalent definition is established for the GAD-7.

Example: PHQ-9 score of 16 (moderately severe) dropping to 8 (mild) = good response

---

When to Seek Professional Help

Get Help Now

In the United States, call or text 988 (Suicide & Crisis Lifeline) or go to the nearest ER (outside the US, call your local emergency number) if:

• Thoughts of suicide or self-harm
• Plan or means to harm yourself
• Thoughts of harming others
• Severe hopelessness or worthlessness
• Inability to care for yourself
• Hallucinations or delusions

Book an Appointment Soon

Schedule appointment if:

• PHQ-9 score ≥15 (moderately severe depression)
• GAD-7 score ≥15 (severe anxiety)
• Significant functional impairment (can't work, care for family, maintain relationships)
• Symptoms worsening rapidly
• New onset of symptoms after major life event

Raise It at Your Next Visit

Discuss with primary care provider if:

• PHQ-9 score 10-14 (moderate depression)
• GAD-7 score 10-14 (moderate anxiety)
• Symptoms present for >2 weeks
• Symptoms interfering with daily life
• No improvement with self-care strategies

---

The Best Approach: Use Both Together

For comprehensive mental health screening, the best practice is:

1. Administer both PHQ-9 and GAD-7 at initial screening (takes 3-5 minutes total)
2. Identify primary symptoms - which domain is more elevated?
3. Check for comorbidity - are both scores elevated?
4. Create treatment plan targeting depression, anxiety, or both
5. Monitor with both tools during treatment, at follow-up visits
6. Track response - for the PHQ-9, a 50% drop together with a score below 10
7. Review treatment with the clinician if scores are not improving

This approach:

• Covers both depression and anxiety symptoms (no questionnaire catches everyone)
• Provides a fuller symptom profile
• Informs treatment selection
• Makes change over time visible

Remember: These are screening tools, not substitutes for professional evaluation. Always follow up positive screens with clinical assessment and appropriate treatment.

---

Key Takeaways

✅ PHQ-9 screens for depression (9 items, focuses on sadness, loss of interest, guilt, suicidal thoughts)

✅ GAD-7 screens for anxiety (7 items, focuses on worry, nervousness, restlessness)

✅ Both use ≥10 as positive screen cutoff, but score ranges differ (PHQ-9: 0-27, GAD-7: 0-21)

✅ Depression and anxiety often occur together - in one large cohort, 67% of people with a depressive disorder also had a current anxiety disorder

✅ The PHQ-9 does not ask about anxiety - someone with anxiety alone can score low on it

✅ PHQ-9 includes a question on thoughts of self-harm (any positive answer to Question 9 needs a clinician's suicide-risk assessment)

✅ Both are screening tools, not diagnostic tools - positive screens need clinical follow-up

✅ Repeat at follow-up visits during treatment to monitor response (for the PHQ-9: a 50% drop together with a score below 10)

✅ Both are free, validated, and quick (3-5 minutes total for both)

✅ Use together for comprehensive screening, or use individually based on primary symptoms

---

Related Tools

• PHQ-9 Calculator - Screen for depression severity
• GAD-7 Calculator - Screen for anxiety severity
• Mental Health Screening Guide - Complete guide to PHQ-9, GAD-7, and other tools

---

Sources

1. PHQ-9 and GAD-7 Clinical Forms - Florida State University
2. The Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS): Initial Validation in Three Clinical Trials - PMC
3. Validation of the PHQ-9 and GAD-7 in Lithuanian Student Sample - PMC
4. Value Added? Pragmatic Analysis of Routine Use of PHQ-9 and GAD-7 Scales in Primary Care - ScienceDirect
5. Patient Health Questionnaire-9 (PHQ-9) - National HIV Curriculum
6. Validation of Brief Screening Measures for Depression and Anxiety in Young People with Substance Use Disorders - PMC
7. GAD-7 and PHQ-9 Clinical Reference - Medi-Stats
8. Severity Classification Using GAD-7 and PHQ-9: National Cross-Sectional Study - JMIR Public Health
9. Instruction Manual: Instructions for Patient Health Questionnaire (PHQ) and GAD-7 Measures - PHQ Screeners
10. The PHQ-9: Validity of a Brief Depression Severity Measure (Kroenke, Spitzer, Williams 2001) - PubMed
11. A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7 (Spitzer et al. 2006) - PubMed
12. Screening for Depression and Suicide Risk in Adults - US Preventive Services Task Force (June 2023)
13. Screening for Anxiety Disorders in Adults - US Preventive Services Task Force (June 2023)
14. Comorbidity Patterns of Anxiety and Depressive Disorders in a Large Cohort Study (Lamers et al. 2011) - PubMed
15. Evaluation of the PHQ-9 for Detecting Major Depression Among Adolescents (Richardson et al. 2010) - PubMed
16. The GAD-7 in Adolescents with Generalized Anxiety Disorder (Mossman et al. 2017) - PubMed
17. Defining Successful Treatment Outcome in Depression Using the PHQ-9 (McMillan, Gilbody, Richards 2010) - PubMed

---

Disclaimer: The PHQ-9 and GAD-7 are screening tools for educational and informational purposes. They are not substitutes for professional medical advice, diagnosis, or treatment. If you have concerns about depression or anxiety, consult with a qualified healthcare provider. If you are experiencing suicidal thoughts, call 988 (Suicide & Crisis Lifeline) immediately.